
Cardiologist

No OPD information available
Aortic Regurgitation
Aortic Valve Stenosis
Transcatheter Aortic Valve Replacement (TAVR)
Acute Coronary Syndrome
Angioplasty
Aortic Valve Replacement
Coronary Heart Disease
Heart Attack
Hypertension
Percutaneous Coronary Intervention (PCI)
Angina
Atherosclerosis
Atrial Fibrillation
Calcinosis
Cardiac Ablation
Cardiomyopathy
Chronic Kidney Disease
Dilated Cardiomyopathy (DCM)
Heart Block
Heart Failure
Mitral Valve Regurgitation
Obesity
Pacemaker Implantation
Stable Angina
Stent Placement
Stroke
Vasoconstriction
Stephen G. Worthley is a male doctor who helps people with heart problems like Aortic Regurgitation, Aortic Valve Stenosis, and more. He uses treatments like Transcatheter Aortic Valve Replacement (TAVR) and Percutaneous Coronary Intervention (PCI) to help his patients feel better.
Stephen G. Worthley talks to his patients in a kind and clear way, making sure they understand their treatment. Patients trust him because he listens to their concerns and explains things well.
To stay updated with new medical information, Stephen G. Worthley reads research papers and attends conferences. This helps him give the best care to his patients.
Stephen G. Worthley works well with other doctors and nurses, sharing knowledge and working together to help patients. He is respected by his colleagues for his expertise and teamwork.
Stephen G. Worthley's work has helped many people live healthier lives. For example, his research on the AMPLATZER Amulet Left Atrial Appendage Occluder has improved treatment for heart conditions.
In a clinical trial called the HighLife TSMVR Feasibility Study, Stephen G. Worthley is helping patients with heart issues by testing a new valve. This could lead to better treatments for people with heart problems.
Overall, Stephen G. Worthley is a caring and skilled doctor who uses the latest knowledge to help his patients. His work makes a positive impact on many lives, and he is respected by both patients and colleagues in the medical field.
Enrollment Status: Recruiting
Published: October 03, 2024
Intervention Type: Device
Study Drug:
Study Phase: Not Applicable
